نتائج البحث - "Carter, Louise"

1

دورية أكاديمية

Development and validation of a Patient Reported Experience Measure for Experimental Cancer Medicines (PREM-ECM) and their carers (PREM-ECM-Carer):Development & validation of PREM-ECMs

المؤلفون: Sawyer, Chelsea, Taylor, Sally, Carter, Louise, Stanworth, Melissa, Davis, Michelle, Thistlewaite, Fiona, Taylor, Jo, Eastwood, Charlotte, Yorke, Janelle

المصدر: Sawyer , C , Taylor , S , Carter , L , Stanworth , M , Davis , M , Thistlewaite , F , Taylor , J , Eastwood , C & Yorke , J 2024 , ' Development and validation of a Patient Reported Experience Measure for Experimental Cancer Medicines (PREM-ECM) and their carers (PREM-ECM-Carer) : Development & validation of PREM-ECMs ' , BMC Cancer , vol. 24 , 500 . https://doi.org/10.1186/s12885-024-11963-xTest

مصطلحات موضوعية: clinical trials, patient experience, questionnaire development, carers, rasch analysis, cancer

العلاقة: https://research.manchester.ac.uk/en/publications/779dc10b-3b3c-4440-9540-6cb514bcdd24Test

الإتاحة: https://doi.org/10.1186/s12885-024-11963-xTest
https://research.manchester.ac.uk/en/publications/779dc10b-3b3c-4440-9540-6cb514bcdd24Test

View record in BASE

2

دورية أكاديمية

PROACT 2.0: A new open-source tool to improve patient-doctor communication in clinical trials

المؤلفون: Agnelli, Luca, Villa, Andrea, Butt, Fouziah, Duca, Matteo, Guidi, Alessandro, Carapezza, Marcello, Addante, Michele, Lenoci, Gaetano, O’Regan, Paul, Russo, Laura, Cresta, Sara, Castano, Alessandra, Ebrahem, Elisabella, Alfieri, Sara, Patil, Akshita, Carter, Louise, Dive, Caroline, De Braud, Filippo Guglielmo, Damian, Silvia

المساهمون: Ministero della Salute, Associazione Italiana per la Ricerca sul Cancro

المصدر: Tumori Journal ; ISSN 0300-8916 2038-2529

الإتاحة: https://doi.org/10.1177/03008916241248007Test

View record in BASE

3

دورية أكاديمية

ATR inhibitor, camonsertib, dose optimization in patients with biomarker-selected advanced solid tumors (TRESR study)

المؤلفون: Fontana, Elisa, Rosen, Ezra, Lee, Elizabeth K, Højgaard, Martin, Mettu, Niharika B, Lheureux, Stephanie, Carneiro, Benedito A, Cote, Gregory M, Carter, Louise, Plummer, Ruth, Mahalingam, Devalingam, Fretland, Adrian J, Schonhoft, Joseph D, Silverman, Ian M, Wainszelbaum, Marisa, Xu, Yi, Ulanet, Danielle, Koehler, Maria, Yap, Timothy A

المصدر: JNCI: Journal of the National Cancer Institute ; ISSN 0027-8874 1460-2105

الإتاحة: https://doi.org/10.1093/jnci/djae098Test

View record in BASE

4

دورية أكاديمية

sj-pdf-1-tmj-10.1177_03008916241248007 – Supplemental material for PROACT 2.0: A new open-source tool to improve patient-doctor communication in clinical trials ...

المؤلفون: Agnelli, Luca, Villa, Andrea, Butt, Fouziah, Duca, Matteo, Guidi, Alessandro, Carapezza, Marcello, Addante, Michele, Lenoci, Gaetano, O’Regan, Paul, Russo, Laura, Cresta, Sara, Castano, Alessandra, Ebrahem, Elisabella, Alfieri, Sara, Patil, Akshita, Carter, Louise, Dive, Caroline, De Braud, Filippo Guglielmo, Damian, Silvia

مصطلحات موضوعية: Medicine

العلاقة: https://dx.doi.org/10.1177/03008916241248007Test

الإتاحة: https://doi.org/10.25384/sage.2570718610.1177/03008916241248007Test
https://sage.figshare.com/articles/journal_contribution/sj-pdf-1-tmj-10_1177_03008916241248007_Supplemental_material_for_PROACT_2_0_A_new_open-source_tool_to_improve_patient-doctor_communication_in_clinical_trials/25707186Test

View record in BASE

5

دورية أكاديمية

Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results

المصدر: Yap , T A , Fontana , E , Lee , E K , Spigel , D R , Højgaard , M , Lheureux , S , Mettu , N B , Carneiro , B A , Carter , L , Plummer , R , Cote , G M , Meric-Bernstam , F , O’Connell , J , Schonhoft , J D , Wainszelbaum , M , Fretland , A J , Manley , P , Xu , Y , Ulanet , D , Rimkunas , V , Zinda , M , Koehler , M , Silverman , I ....

مصطلحات موضوعية: Ataxia Telangiectasia, Ataxia Telangiectasia Mutated Proteins/genetics, DNA Damage, Female, Humans, Ovarian Neoplasms/drug therapy, Protein Kinase Inhibitors/pharmacokinetics

العلاقة: https://research.manchester.ac.uk/en/publications/7dbadb2f-01c1-4f4d-ac15-c0db095b3d17Test

الإتاحة: https://doi.org/10.1038/s41591-023-02399-0Test
https://research.manchester.ac.uk/en/publications/7dbadb2f-01c1-4f4d-ac15-c0db095b3d17Test
https://www.mendeley.com/catalogue/79756811-2e37-3ae0-acb8-ee259e0979d7Test/
http://www.scopus.com/inward/record.url?scp=85160946619&partnerID=8YFLogxKTest

View record in BASE

6

دورية أكاديمية

A Phase I/II trial of Oral SRA737 (a Chk1 Inhibitor) given in combination with low-dose gemcitabine in patients with advanced cancer

المؤلفون: Jones, Robert, Plummer, Ruth, Moreno, Victor, Carter, Louise, Roda, Desamparados, Garralda, Elena, Kristeleit, Rebecca, Sarker, Debashis, Arkenau, Tobias, Roxburgh, Patricia, Walter, Harriet S., Blagden, Sarah, Anthoney, Alan, Klencke, Barbara J., Kowalski, Mark M., Banerji, Udai

وصف الملف: application/pdf

العلاقة: https://orca.cardiff.ac.uk/id/eprint/154282/8/331.pdfTest; Jones, Robert https://orca.cardiff.ac.uk/view/cardiffauthors/A007428W.htmlTest orcid:0000-0003-3576-9496 orcid:0000-0003-3576-9496, Plummer, Ruth, Moreno, Victor, Carter, Louise, Roda, Desamparados, Garralda, Elena, Kristeleit, Rebecca, Sarker, Debashis, Arkenau, Tobias, Roxburgh, Patricia, Walter, Harriet S., Blagden, Sarah, Anthoney, Alan, Klencke, Barbara J., Kowalski, Mark M. and Banerji, Udai 2023. A Phase I/II trial of Oral SRA737 (a Chk1 Inhibitor) given in combination with low-dose gemcitabine in patients with advanced cancer. Clinical Cancer Research 29 (2) , pp. 331-340. 10.1158/1078-0432.CCR-22-2074 https://doi.org/10.1158/1078-0432.CCR-22-2074Test file https://orca.cardiff.ac.uk/id/eprint/154282/8/331.pdfTest

الإتاحة: https://doi.org/10.1158/1078-0432.CCR-22-2074Test
https://orca.cardiff.ac.uk/id/eprint/154282Test/
https://orca.cardiff.ac.uk/id/eprint/154282/8/331.pdfTest

View record in BASE